MyFinsight
Home
Blog
About
Cash and cash
equivalents
$18,855K
(75.67%↑ Y/Y)
Marketable debt securities
$14,141K
(-81.92%↓ Y/Y)
Prepaid expenses and
other current assets
$2,266K
(-65.35%↓ Y/Y)
Restricted cash
$1,472K
(0.00%↑ Y/Y)
Total current assets
$36,734K
(-63.25%↓ Y/Y)
Operating lease
right-of-use asset
$10,951K
(-7.56%↓ Y/Y)
Property and equipment,
net
$7,237K
(-18.90%↓ Y/Y)
Total assets
$54,922K
(-55.43%↓ Y/Y)
Total liabilities and
stockholders' equity
$54,922K
(-55.43%↓ Y/Y)
Total liabilities
$43,482K
(22.24%↑ Y/Y)
Total stockholders'
equity
$11,440K
(-86.95%↓ Y/Y)
Accumulated deficit
-$491,795K
(-22.01%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$4K
(20.00%↑ Y/Y)
Total current
liabilities
$27,474K
(55.41%↑ Y/Y)
Operating lease
liabilities, net of current...
$16,008K
(-10.23%↓ Y/Y)
Additional paid-in capital
$503,176K
(2.55%↑ Y/Y)
Common stock, 0.001 par
value per share...
$63K
(1.61%↑ Y/Y)
Accrued expenses and
other current...
$12,381K
(84.85%↑ Y/Y)
Private placement
advance liability
$10,000K
Accounts payable
$3,269K
(-65.27%↓ Y/Y)
Operating lease
liabilities, current portion
$1,824K
(16.33%↑ Y/Y)
Back
Back
Balance Sheet
Pyxis Oncology, Inc. (PYXS)
Pyxis Oncology, Inc. (PYXS)
source: myfinsight.com